Non-Invasive Prenatal Testing (NIPT) screens for chromosomal abnormalities using foetal DNA in the mother’s bloodstream. Performed from 10 weeks, no risk to mother or baby.
What Does NIPT Screen For?
Trisomy 21 (Down’s syndrome), Trisomy 18 (Edwards’ syndrome), Trisomy 13 (Patau’s syndrome), sex chromosome abnormalities, and — with extended panels — microdeletions.
Who Should Consider NIPT?
Women aged 35+, personal or family history of chromosomal conditions, pregnancies following IVF, abnormal first trimester combined screening result.
Accuracy
Detection rate over 99% for Trisomy 21. NIPT is a screening test — positive results require confirmatory diagnostic testing (CVS or amniocentesis).
The Process
Simple maternal blood draw. Results typically available within 7–10 working days.
To arrange NIPT as part of your antenatal care with Assist. Prof. Dr. Muzaffer Uçarer, contact UCARER Women’s Health.